A Comprehensive Parameter-by-Parameter Guide for Medical Professionals, Students & Pathologists
The Complete Blood Count (CBC) is the most frequently ordered laboratory test worldwide. It provides a quantitative and qualitative analysis of the three major cellular components of blood: Red Blood Cells (Erythrocytes), White Blood Cells (Leukocytes), and Platelets (Thrombocytes).
Modern automated hematology analyzers use principles of electrical impedance, light scattering, fluorescence flow cytometry, and cytochemical staining to generate CBC results. A standard CBC panel produces 15β25 measurable parameters, each with distinct clinical significance.
Total number of erythrocytes per unit volume of blood. Measured by electrical impedance (Coulter principle) or optical light scatter in automated analyzers.
RBC count is foundational for diagnosing anemia type. Low RBC with low Hb indicates true anemia. Critical first step in workup: combined with Hct and MCV to classify as microcytic, normocytic, or macrocytic, guiding specific investigations (iron studies, B12/folate, reticulocyte count).
Polycythemia Vera (PV): Markedly elevated RBC (often >6.0 Γ 10ΒΉΒ²/L) with elevated Hct (>54%), normal Oβ saturation = major diagnostic criterion. RBC count helps distinguish PV from secondary polycythemia.
Persistently low RBC with compensatory reticulocytosis is hallmark of chronic hemolytic anemia (hereditary spherocytosis, sickle cell, thalassemia major). RBC count alone cannot distinguish; combine with RPI and PBS morphology.
RBC count <2.0 Γ 10ΒΉΒ²/L indicates severe anemia requiring urgent transfusion evaluation. Progressive decline predicts marrow failure (aplastic anemia, MDS) if reticulocyte response inadequate.
Neonates have higher RBC counts (5.0β6.5 Γ 1012/L) due to fetal erythropoiesis stimulated by low intrauterine pOβ. Values gradually decline to adult levels by 3β6 months of age (physiological anemia of infancy).
The concentration of hemoglobin in whole blood. Measured spectrophotometrically using the cyanmethemoglobin (HiCN) method or sodium lauryl sulfate (SLS) method. Hemoglobin is the primary oxygen-carrying metalloprotein β a tetramer of 2Ξ± and 2Ξ² globin chains, each bound to a heme group containing FeΒ²βΊ.
Hemoglobin is THE primary parameter for anemia diagnosis. Severity correlates with clinical symptoms: Hb 7β9 g/dL = fatigue/dyspnea at exertion; Hb <7 g/dL = risk of cardiac decompensation, myocardial ischemia, stroke. Directly determines transfusion thresholds in clinical practice.
Sickle Cell Disease (HbSS): Hb typically 7β10 g/dL due to chronic hemolysis. Thalassemia Major: Hb <7 g/dL requires regular transfusions. Hemoglobin electrophoresis MUST be ordered when abnormal Hb variants detected on analyzer.
Acute hemorrhage: Hb drop >1 g/dL in hours (before Hct drops) = plasma shift into interstitium. Chronic disease: gradual Hb decline allows physiological compensation. RBC count often NORMAL in chronic disease anemia despite low Hb = key differentiator.
Serial Hb tracks efficacy of iron/B12/folate replacement, EPO therapy, transfusions, and chemotherapy. Expected rise in iron deficiency = 0.2 g/dL/day. Failure to rise suggests non-compliance, continued blood loss, or alternate diagnosis.
Hb <5 g/dL increases tissue hypoxia risk exponentially. Combined with Hct, predicts cardiac output demands. In perioperative settings: Hb <7 g/dL generally warrants transfusion pre-emptively in high-risk patients.
Lipemia, hyperbilirubinemia, and very high WBC counts (>100 Γ 10βΉ/L) can falsely elevate Hb values. Carboxyhemoglobin (HbCO) and methemoglobin (MetHb) are included in total Hb measurement but do not carry oxygen.
The proportion of blood volume occupied by red blood cells, expressed as a percentage or L/L. In automated analyzers, Hct is a calculated value: Hct = MCV Γ RBC count. In manual methods, determined by centrifugation (Wintrobe or microhematocrit method).
Hct is a calculated marker of blood composition. Elevated Hct (β₯54%) with elevated RBC/Hb = true polycythemia OR hemoconcentration (dehydration). Low Hct despite normal RBC/Hb may indicate dilutional state (SIADH, heart failure). Hct >60% = hyperviscosity risk (thrombosis, stroke in PV).
Critical Finding: Early hemorrhage shows βRBC/Hb but NORMAL Hct initially (ratio delay). After 24β48 hrs, fluid shifts normalize Hct. Serial Hct trending (not single value) is crucial: β1% per 8 hrs = ongoing bleeding. Hct <30% = massive transfusion protocol likely needed.
PV with Hct >55% increases blood viscosity β thrombotic complications (CVA, MI, DVT/PE, splanchnic vein thrombosis). Target Hct <45% in PV patients. This Hct threshold may indicate need for phlebotomy or cytoreductive therapy.
Modern transfusion thresholds based on Hb not Hct. However, Hct contextualizes: Hct 24% + Hb 8 g/dL = normochromic picture; Hct 20% + Hb 8 g/dL = hypochromic (suspect iron deficiency). Restrictive transfusion strategy (Hb 7β9 g/dL) reduces complications vs liberal strategy.
Hct <20% pre-op = increased cardiac morbidity risk. Major surgery with Hct <25% may warrant pre-operative transfusion. Cardiac patients with Hct <25% at higher MI risk during perioperative period.
In normocytic normochromic states: Hct β 3 Γ Hb and RBC Γ 3 β Hb. Deviations suggest abnormal cell size, Hb content, or analytical error. This is a useful quick quality check.
Reticulocytes are immature RBCs containing residual RNA (ribosomal RNA). They are released from bone marrow and mature into RBCs in 1β2 days in circulation. Detected by supravital staining (New Methylene Blue / Brilliant Cresyl Blue) or fluorescent RNA dyes in automated analyzers.
CRC = Retic% Γ (Patient Hct / Normal Hct)
RPI = CRC / Maturation Factor β RPI >3 = adequate marrow response; RPI <2 = inadequate
Rate at which RBCs sediment in one hour. A non-specific marker of inflammation. Gold standard: Westergren method (200mm vertical tube, citrated blood). ESR depends on rouleaux formation driven by acute-phase proteins (fibrinogen, immunoglobulins).
Total number of leukocytes per unit volume. WBCs are the body's defense system β comprising granulocytes (neutrophils, eosinophils, basophils) and agranulocytes (lymphocytes, monocytes). Measured by impedance or optical methods after RBC lysis.
At birth: neutrophil predominant. By day 4β7: first crossover β lymphocytes become dominant. At age 4β7 years: second crossover β neutrophils regain dominance (adult pattern). This is the famous "double crossover" of WBC differential in children.
Most abundant WBC type in adults. First responders to bacterial infection. Contain primary (azurophilic) and secondary (specific) granules. Lifespan in circulation: 6β8 hours. Half exist in the marginated pool (attached to vessel walls).
Left Shift: Increase in immature forms (bands, metamyelocytes, myelocytes) β seen in acute bacterial infections, sepsis. Right Shift: Hypersegmented neutrophils (>5 lobes) β pathognomonic of megaloblastic anemia (B12/folate deficiency).
Key mediators of adaptive immunity. T-cells (60β70%) β cell-mediated immunity; B-cells (10β20%) β humoral immunity / antibody production; NK cells (10β15%) β innate immune surveillance. Small round cells with scant cytoplasm on PBS.
Largest WBC. Circulate 1β3 days then migrate to tissues β become macrophages (Kupffer cells in liver, alveolar macrophages, microglia in brain, osteoclasts in bone). Key in chronic inflammation and granuloma formation.
β¬ in: TB, endocarditis, CMML, recovery from neutropenia | Mnemonic: "Monocytes for Months" (chronic infections)
Bilobed nucleus, bright orange-red granules with eosin staining. Major Basic Protein (MBP) in granules is toxic to parasites. Key in allergic responses and parasitic defense.
β¬ in: NAACP β Neoplasia, Asthma/Allergy, Addison's, Collagen vascular disease, Parasites | Churg-Strauss, LΓΆffler syndrome
Rarest WBC. Large dark blue-black metachromatic granules obscure the nucleus. Contain histamine and heparin. Tissue counterpart: Mast cells. Express high-affinity IgE receptors (FcΞ΅RI).
β¬ in: CML (highly characteristic), myeloproliferative neoplasms, hypothyroidism, ulcerative colitis
Basophilia is the most specific marker for CML among the WBC differential findings. Combined with marked leukocytosis, left shift, and eosinophilia β strongly suggests CML (confirm with BCR-ABL1 / Philadelphia chromosome).
Anucleate cytoplasmic fragments derived from megakaryocytes in bone marrow. Regulated by thrombopoietin (TPO) produced primarily in the liver. Each megakaryocyte produces ~1000β3000 platelets. Lifespan: 8β10 days. ~β sequestered in spleen.
EDTA-dependent platelet clumping causes falsely low counts in ~0.1% of patients. Always check PBS for clumps. Remedy: redraw in citrate tube and correct count Γ 1.1 (dilution factor).
Average size of platelets. Young platelets (reticulated) are larger and more hemostatically active. β¬MPV = active thrombopoiesis (ITP, recovery). β¬MPV = marrow failure, Wiskott-Aldrich syndrome (characteristically small platelets).
Measure of variation in platelet size (anisocytosis of platelets). β¬PDW = reactive thrombocytosis, MPN, platelet activation. Used alongside MPV for differential diagnosis of thrombocytopenia causes.
ITP: β¬MPV + β¬PDW (large young platelets replacing destroyed ones). Aplastic anemia: β¬MPV + normal PDW (marrow failure, small uniform platelets). Bernard-Soulier Syndrome: Giant platelets β very high MPV.
Average volume of a single RBC in femtoliters (fL). The most important index for classifying anemias morphologically. Directly measured by analyzers or calculated: MCV = Hct (%) / RBC (millions/Β΅L) Γ 10
| Classification | MCV | Key Causes |
|---|---|---|
| Microcytic | <80 fL | Iron deficiency, Thalassemia, Anemia of chronic disease, Sideroblastic anemia, Lead poisoning β Mnemonic: TAILS |
| Normocytic | 80β100 fL | Acute hemorrhage, Hemolytic anemia, ACD, Aplastic anemia, CKD, Mixed deficiency |
| Macrocytic | >100 fL | Megaloblastic: B12/Folate deficiency. Non-megaloblastic: Liver disease, alcoholism, hypothyroidism, MDS, reticulocytosis |
Mentzer Index = MCV/RBC: >13 β Iron deficiency; <13 β Thalassemia trait. Also: RDW is β¬ in IDA (anisocytosis) but normal in thalassemia trait (uniform microcytosis).
Average weight of Hb per RBC (in picograms). MCH = Hb (g/dL) / RBC (millions/Β΅L) Γ 10. Parallels MCV β β¬ in microcytic, β¬ in macrocytic anemias.
Average Hb concentration per RBC. MCHC = Hb (g/dL) / Hct (%) Γ 100. Most stable RBC index. Classifies as normochromic or hypochromic.
Very few conditions raise MCHC: Hereditary Spherocytosis (most classic), cold agglutinins (artifact), severe dehydration. MCHC >36 should prompt PBS review for spherocytes and a DAT/Coombs test.
Coefficient of variation of RBC volume. Quantifies anisocytosis (variation in RBC size). Generated from the RBC histogram. Higher RDW = more size variation.
| MCV | Normal RDW | High RDW |
|---|---|---|
| Microcytic (<80) | Thalassemia trait, ACD | Iron deficiency anemia, HbH disease |
| Normocytic (80β100) | ACD, CKD, acute hemorrhage | Early iron/B12/folate deficiency, mixed deficiency, sickle cell |
| Macrocytic (>100) | Aplastic anemia, liver disease | B12/Folate deficiency, MDS, immune hemolytic anemia |
RDW has emerged as an independent prognostic marker for mortality in heart failure, sepsis, COVID-19, and general ICU patients β elevated RDW correlates with oxidative stress and chronic inflammation beyond hematologic disease.
The differential count provides relative (%) and absolute counts of each WBC type. Always interpret absolute counts rather than percentages, as percentages can be misleading when total WBC is abnormal.
| Cell Type | Relative % | Absolute Count | Key Function |
|---|---|---|---|
| Neutrophils (Segs) | 40β70% | 2.0β7.0 Γ 10βΉ/L | Phagocytosis of bacteria; first responders |
| Bands (Stabs) | 0β5% | 0β0.7 Γ 10βΉ/L | Immature neutrophils; β¬ = left shift |
| Lymphocytes | 20β40% | 1.0β4.0 Γ 10βΉ/L | Adaptive immunity (T & B cells, NK cells) |
| Monocytes | 2β8% | 0.2β0.8 Γ 10βΉ/L | Phagocytosis; APC; chronic inflammation |
| Eosinophils | 1β4% | 0.04β0.4 Γ 10βΉ/L | Parasitic defense; allergic responses |
| Basophils | 0β1% | 0β0.1 Γ 10βΉ/L | Histamine/heparin release; IgE-mediated |
The PBS is the pathologist's most valuable tool. It provides morphological information that no analyzer can replicate.
Thalassemia, HbC, liver disease, post-splenectomy, iron deficiency
Sickle cell disease (HbSS) β irreversibly sickled cells
Hereditary spherocytosis, AIHA, burns, Clostridium sepsis
Myelofibrosis (most classic), myelophthisic anemia, thalassemia major
TTP, HUS, DIC, MAHA, prosthetic heart valves β MICROANGIOPATHY
Hereditary elliptocytosis, iron deficiency, megaloblastic anemia
Multiple myeloma, WaldenstrΓΆm's, chronic inflammation (βfibrinogen/Ig)
G6PD deficiency β Heinz body removal by splenic macrophages
Nuclear remnants β post-splenectomy, functional asplenia, megaloblastic
Lead poisoning, thalassemia, sideroblastic anemia, MDS
Compare to age- and sex-specific reference ranges. WHO defines anemia as Hb <13 g/dL (M) and <12 g/dL (F).
MCV is the single most useful index. Narrows the differential diagnosis of anemia dramatically.
High RDW = anisocytosis. Differentiates IDA (high RDW) from thalassemia trait (normal RDW).
RPI >3 = adequate response (hemolysis/hemorrhage). RPI <2 = hypoproliferative (marrow failure/deficiency).
Use absolute counts. Identify neutrophilia/neutropenia, lymphocytosis, eosinophilia, or left shift.
Rule out pseudothrombocytopenia. Correlate with MPV and clinical picture.
The PBS is the gold standard for morphological assessment. Look for diagnostic pointers: schistocytes, blasts, parasites, inclusions.
Simultaneous reduction in all three cell lines (RBC, WBC, Platelets). Always warrants urgent investigation including bone marrow examination.